Psychological Factors Affecting Other Medical Conditions (PFAMC) is a diagnosis introduced in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). It refers to situations where psychological or behavioral factors adversely impact an individual's medical condition, either by exacerbating the condition or hindering its treatment (American Psychiatric Association, 2023). The main hallmark of this disorder is the presence of a recognized medical condition along with psychological factors that influence its onset, severity, exacerbation, or recovery.

Individuals with PFAMC might display a variety of psychological or behavioral symptoms. Some common presentations include high levels of anxiety about a medical condition, denial of the severity of a medical condition, or resistance to recommended medical treatment due to underlying psychological issues. For instance, a person with diabetes might demonstrate poor adherence to diet or medication regimens due to underlying depression or anxiety, thus exacerbating their medical condition (Sirri & Fava, 2013). The psychological factors may manifest as negative health behaviors, maladaptive coping strategies, or psychological stress that directly impacts the physiological functioning, thereby affecting the medical condition.

Understanding the interplay between psychological and medical conditions is vital for comprehensive patient care. It underscores the importance of interdisciplinary collaboration between mental health professionals and medical teams to address the patient's psychological and physical health needs (Dimsdale et al., 2011).

Diagnostic Criteria

The DSM-5-TR provides specific diagnostic criteria for Psychological Factors Affecting Other Medical Conditions (PFAMC). According to the DSM-5 (American Psychiatric Association, 2023):

• Medical Symptom or Condition: A medical condition must not be purely a mental disorder.
• Psychological or Behavioral Factors: These factors must adversely affect the medical condition in at least one of the following ways:
• They have influenced the course of the medical condition by making it more challenging to treat.
• They interfere with the treatment of the medical condition.
• They represent additional health risks to the individual.
• They have exacerbated the health condition or increased the risk of suffering from the health condition.
• Clinical Significance: The psychological or behavioral factors associated with the medical condition are clinically significant. This is shown by the fact that they lead to increased suffering, pose a risk of morbidity or mortality, or necessitate clinical intervention.
• Exclusion of Mental Disorders: If the psychological or behavioral factors can be better explained by another mental disorder, then the diagnosis of PFAMC is not assigned.

Furthermore, the DSM-5-TR specifies a severity criterion for this diagnosis, which can be categorized as mild, moderate, severe, or extreme, depending on the level of medical risk, the severity of increased suffering, or the necessity for clinical intervention due to the psychological factors (American Psychiatric Association, 2023).

It is imperative to note that the diagnosis of PFAMC does not imply that the medical condition is caused or induced by psychological factors; instead, it acknowledges that these factors can significantly impact the course and management of the medical condition.

The Impacts

Psychological Factors Affecting Other Medical Conditions (PFAMC) can substantially impact an individual's health and well-being. One of the primary consequences is the exacerbation of the medical condition itself. For instance, individuals experiencing high stress levels may face difficulties managing chronic conditions such as diabetes or hypertension, potentially leading to poorer health outcomes (Dimsdale, 2008). Stress has been implicated in negatively affecting blood glucose regulation in people with diabetes and influencing blood pressure regulation in hypertensive patients (Surwit et al., 1992).

Additionally, PFAMC can interfere with effective treatment adherence. For example, individuals with depressive symptoms may exhibit reduced compliance with medical recommendations, leading to a diminished efficacy of treatments and overall poorer prognosis (DiMatteo et al., 2000). This reduced adherence can also lead to increased healthcare utilization, with patients more likely to require hospitalizations or emergency care due to uncontrolled symptoms or complications (Katon et al., 2003).

Moreover, PFAMC can introduce additional health risks. Anxiety, for example, can trigger cardiac symptoms in patients with cardiovascular diseases, leading to heightened risks of cardiac events (Rozanski et al., 1999). Such psychological factors can also decrease one's tolerance for discomfort or pain, complicating the clinical picture and potentially delaying recovery.

Lastly, the presence of PFAMC often correlates with decreased quality of life. The interaction between psychological and medical factors can lead to heightened suffering, decreased daily functioning, and reduced overall life satisfaction (Smith & Zautra, 2008).

In essence, psychological factors can have many impacts on medical conditions, influencing their course, management, and the individual's overall well-being.

The Etiology (Origins and Causes)

The etiology of Psychological Factors Affecting Other Medical Conditions (PFAMC) involves an intricate interplay of biological, psychological, and social factors.

• Biological Factors: Some medical conditions can inherently cause psychological symptoms. For example, certain endocrine disorders can lead to mood and anxiety symptoms. Chronic pain or inflammation can also affect neurotransmitter function, potentially leading to depression or anxiety (Miller et al., 2009).
• Psychological Factors: Personal coping styles, prior traumatic experiences, and cognitive patterns can influence how an individual responds to a medical diagnosis or its symptoms. For instance, someone with a history of anxiety might have an exaggerated response to a benign medical symptom, which could amplify that symptom's physical experience (Asmundson & Taylor, 1996).
• Social and Environmental Factors: Social support, or lack thereof, can significantly influence the course of a medical condition. A person with strong social support might fare better in managing a chronic illness than someone socially isolated. Environmental stressors, such as job-related stress or financial difficulties, can exacerbate medical conditions by increasing overall stress and reducing self-care capacity (Cohen et al., 2007).
• Behavioral Factors: Certain behaviors, driven by psychological factors, can directly impact medical conditions. For example, someone with depression might overeat or abstain from physical activity, behaviors which can negatively affect conditions like diabetes or cardiovascular diseases (Simon et al., 2009).
• Cognitive and Perceptual Factors: How individuals perceive and understand their medical condition can influence its course. Maladaptive health beliefs, catastrophic thinking, or misinterpretations of bodily sensations can intensify symptoms or create barriers to effective treatment (Rief & Broadbent, 2007).

The interaction of these factors underscores the importance of a biopsychosocial approach to understanding and managing PFAMC. Treating only the condition's medical or psychological facet might not yield optimal results, given the interconnected nature of these factors.

Comorbidities

Psychological Factors Affecting Other Medical Conditions (PFAMC) often do not exist in isolation and can coexist with other psychological and medical conditions, leading to comorbidities. These comorbidities can complicate the clinical picture and influence the overall management and prognosis of PFAMC.

• Mental Health Disorders: Many individuals with PFAMC also have concurrent mental health disorders. Depression and anxiety disorders are among the most common (Evans et al., 2005). For example, a patient with cardiovascular disease might also exhibit symptoms of clinical depression, which can further complicate their medical management.
• Substance Use Disorders: Substance use can be both a cause and a consequence of PFAMC. Some individuals might turn to substances like alcohol, tobacco, or drugs as a coping mechanism for their medical condition, further deteriorating their health (Sullivan et al., 2005).
• Chronic Pain Syndromes: Conditions like fibromyalgia, chronic fatigue syndrome, and irritable bowel syndrome often have a vital psychological component. These conditions can coexist with PFAMC, where psychological factors amplify pain's perceived intensity and distress (Drossman et al., 1999).
• Somatic Symptom Disorders: Patients with somatic symptom disorders focus more on physical symptoms, which may not have a clear medical cause. This heightened focus can exacerbate existing medical conditions, creating a complex interplay between psychological factors and medical symptoms (Henningsen et al., 2003).
• Personality Disorders: Certain personality traits or disorders might make individuals more susceptible to PFAMC. For instance, those with borderline or dependent personality disorders might react more intensely to medical symptoms or have challenges adhering to medical advice (Frankenburg & Zanarini, 2006).

Recognizing and addressing these comorbidities is crucial for comprehensive patient care. These additional conditions can influence treatment choices, therapy adherence, and patient outcomes.

Risk Factors

Risk factors for Psychological Factors Affecting Other Medical Conditions (PFAMC) encompass a broad range of biological, psychological, and socio-environmental variables that make an individual more susceptible to the adverse interplay between psychological and medical conditions.

• Biological Risk Factors: Individuals with a history of neurochemical imbalances or endocrine disorders, such as thyroid dysfunction or adrenal disorders, might be at increased risk, as these conditions can inherently cause mood disturbances (Raison & Miller, 2003).
• Genetic Predisposition: A family history of mental health disorders or certain medical conditions may predispose an individual to develop PFAMC (Kendler et al., 2002).
• Psychological Vulnerabilities: Individuals with a history of trauma, past abuse, or adverse childhood events may have heightened emotional responses to medical issues or interpret bodily sensations in a more distressing manner (Anda et al., 2006).
• Chronic Stress: Chronic exposure to stressors, whether relational, financial, occupational, or others, can be a significant risk factor. Chronic stress affects psychological well-being and has known physiological consequences, such as impaired immune functioning (Cohen et al., 2007).
• Maladaptive Coping Mechanisms: Reliance on substances (alcohol, drugs) or behaviors (overeating, withdrawal) to cope with stress or distress can elevate the risk of PFAMC (Sullivan et al., 2005).
• Socio-Environmental Factors: Individuals living in environments with limited access to healthcare, inadequate social support, or high levels of environmental stressors may be more susceptible to PFAMC (Evans et al., 2005).
• Previous Mental Health Conditions: A history of anxiety, depression, or other mental health disorders can be a risk factor, as it may amplify the psychological response to medical conditions or symptoms (Simon et al., 2009).

Awareness of these risk factors is essential for healthcare professionals to identify, manage, and possibly prevent the onset or exacerbation of PFAMC in susceptible individuals.

Case Study

Patient Profile: Sarah Mitchell, age 38. A Bank Manager, divorced, single mother of two children (ages 6 and 9).

Presenting Problem: Sarah visited her primary care physician complaining of chronic lower back pain that she has had for the past 18 months. Over-the-counter pain medications provided minimal relief. The pain intensified during work hours and seemed to ease slightly when she was at home during weekends. She also reported difficulty sleeping, which she attributed to the pain.

Medical History: Sarah had a minor car accident two years ago. Post-accident medical examinations, including X-rays and MRIs, revealed no significant injury to her spine or surrounding structures. Other than the accident, Sarah's medical history was unremarkable.

Psychological History: Upon further consultation with a psychologist, Sarah revealed that she had been experiencing increased stress at work since her promotion to bank manager around when her pain began. This position came with added responsibilities and longer working hours. Furthermore, she was navigating a messy divorce and was now responsible for her children without much support from her ex-husband. She reported feelings of anxiety, occasional panic attacks, and symptoms consistent with mild depression.

Assessment and Findings: A detailed psychological evaluation indicated that her emotional and psychological distress might influence Sarah's physical pain. While she did have an actual physical incident (the car accident), the absence of structural damage suggested that her chronic pain might be perpetuated or exacerbated by psychological factors.

The psychologist identified several risk factors:

• High occupational stress.
• Recent life-changing events (divorce).
• Increased responsibility and reduced support at home.
• A history of a traumatic event (car accident), even if no severe physical injury was diagnosed.

Intervention: Sarah was introduced to a multidisciplinary team consisting of her primary care physician, a pain management specialist, a psychologist, and a physical therapist.

• Cognitive Behavioral Therapy (CBT): To help her develop coping mechanisms, address her anxiety and depressive symptoms, and change her pain perception.
• Physical Therapy: A tailored exercise regimen was prescribed to strengthen her back muscles and improve her posture.
• Pain Management: Sarah was given a combination of non-narcotic pain relievers and muscle relaxants. She was also taught relaxation techniques to help ease muscle tension.
• Work-life Balance Counseling: Sarah received counseling on managing her work-related stress and was encouraged to delegate tasks and take regular breaks.

Outcome: Over the next six months, with consistent therapy and interventions, Sarah reported a gradual reduction in her pain levels. She also developed better-coping mechanisms for her stress, improved her sleep quality, and felt more equipped to handle her responsibilities both at work and home.

Conclusion: Sarah's case highlights the intricate relationship between psychological stressors and physical symptoms. A comprehensive approach addressing her physical and psychological condition was crucial for her recovery.

Recent Psychology Research Findings

Psychological factors have increasingly been recognized as crucial determinants in various medical conditions' onset, progression, and outcome. Recent research highlights the multifaceted interplay between psychological processes and physical health.

Stress and Immunity: Chronic psychological stress has been linked to impaired immune function. Cohen et al. (2019) found that individuals under prolonged stress, such as caregivers for dementia patients, showed reduced immune responses to vaccines and increased susceptibility to viral infections. This study provides empirical evidence for the longstanding belief that stress can "wear down" the body.

Depression and Cardiovascular Disease: Recent studies have shown that depression, even in mild forms, can predict cardiovascular disease. Jackson et al. (2020) conducted longitudinal research, demonstrating that individuals with depressive symptoms were more likely to develop heart conditions. The mechanisms include inflammation, autonomic nervous system dysregulation, and endothelial dysfunction.

Mindfulness and Chronic Pain: Zeidan and Vago (2019) explored the role of mindfulness meditation in pain management. They found that practicing mindfulness could reduce pain perception by altering brain activity in regions associated with pain processing. This points to the potential of non-pharmacological interventions in managing chronic pain conditions.

Social Support and Cancer Prognosis: The importance of social relationships in medical outcomes was highlighted by Kroenke et al. (2021). In their study on breast cancer patients, those with robust social support systems had a better prognosis and reduced mortality compared to socially isolated individuals. This emphasizes the role of psychosocial factors in determining health outcomes.

Health Anxiety and Medical Utilization: Health anxiety, a preoccupation with having a severe illness despite medical reassurance, has been linked to increased medical service utilization. As Fergus and Spada (2020) noted, individuals with heightened health anxiety tend to seek repeated medical consultations, which can strain healthcare systems and lead to unnecessary interventions.

The growing body of research in this domain underscores the significance of integrating psychological and medical care for comprehensive patient management.

Treatment and Interventions

Treatment and interventions for Psychological Factors Affecting Other Medical Conditions (PFAMC) are multifaceted, aiming to address the underlying psychological factors and their impact on the medical condition.

• Cognitive Behavioral Therapy (CBT): One of the most researched interventions, CBT assists patients in identifying and modifying maladaptive thoughts and behaviors contributing to or exacerbating their medical conditions. Hofmann, Asnaani, Vonk, Sawyer, and Fang (2012) provided evidence for the effectiveness of CBT in treating a wide range of conditions influenced by psychological factors, from cardiovascular diseases to chronic pain.
• Relaxation Techniques: Techniques such as progressive muscle relaxation, deep breathing exercises, and guided imagery can help reduce stress and anxiety, potentially alleviating symptoms of PFAMC. Lehrer and Gevirtz (2014) found that these techniques could be particularly effective in conditions like hypertension and irritable bowel syndrome.
• Biofeedback: By providing real-time data about physiological functions, biofeedback can help patients better control specific physiological responses. A study by Frank, Khorshid, Kiffer, Moravec, and McKee (2010) suggested that biofeedback could be particularly useful in managing cardiovascular diseases, migraines, and chronic pain.
• Mindfulness and Meditation: Mindfulness-based interventions, such as Mindfulness-Based Stress Reduction (MBSR), have shown promise in managing PFAMC. Goyal et al. (2014) found that MBSR could help reduce symptoms of pain, depression, and anxiety in various medical conditions.
• Medication: Antidepressants, anxiolytics, and other psychotropic medications might be prescribed to manage underlying psychological symptoms, which can subsequently improve the medical condition. Rief, Nestoriuc, and Von Lilienfeld-Toal (2008) indicated that these medications could benefit conditions like chronic pain and gastrointestinal disorders when psychological factors are at play.
• Patient Education: Educating patients about the link between their psychological factors and medical conditions can be empowering. Understanding this connection may make patients more inclined to engage in treatments and adopt healthier behaviors. Lorig and Holman (2003) highlighted the positive outcomes of patient education in chronic disease management.
• Multidisciplinary Approach: Given the complexity of PFAMC, a team approach that includes medical doctors, psychologists, physical therapists, and other professionals is often necessary to provide comprehensive care. This approach ensures that the condition's psychological and medical aspects are addressed simultaneously (Fava et al., 2017).

Addressing PFAMC requires a holistic approach that encompasses a range of treatments and interventions tailored to the individual's specific psychological and medical needs.

Implications if Untreated

If Psychological Factors Affecting Other Medical Conditions (PFAMC) are left untreated, the implications can be wide-ranging and severe for the patient's physical and psychological well-being.

• Worsening of Medical Symptoms: Unaddressed psychological factors can exacerbate the symptoms of the medical condition. For example, Dickens, McGowan, Clark-Carter, and Creed (2002) found that depression in patients with chronic physical health problems can intensify pain, fatigue, and functional impairment. This cyclical relationship can result in progressively declining health.
• Decreased Adherence to Treatment: Patients with untreated PFAMC might be less likely to adhere to medical regimens. Dimatteo, Lepper, and Croghan (2000) discovered that depression was associated with nonadherence to medical treatment recommendations, which could lead to poorer health outcomes.
• Reduced Quality of Life: PFAMC, when not managed, can severely limit a person's daily functioning and overall life satisfaction. According to Bair, Robinson, Katon, and Kroenke (2003), individuals with coexisting chronic pain and depression reported significant reductions in their quality of life, comparable to those with severe disabling medical disorders.
• Increased Healthcare Utilization and Costs: The intertwining of psychological and medical issues can lead to more frequent doctor visits, hospitalizations, and diagnostic tests. Katon et al. (2003) demonstrated that patients with coexisting depression and chronic medical illnesses had higher healthcare costs than those with just a chronic medical illness.
• Heightened Risk of Comorbidities: PFAMC can make an individual more susceptible to other medical and psychological conditions. Carney, Freedland, and Miller (2002) showed that depression in coronary heart disease patients increased the risk of subsequent cardiac events and mortality.
• Elevated Risk of Mortality: The intertwined nature of psychological factors and medical conditions can impact survival rates. For instance, Barth, Schumacher, and Herrmann-Lingen (2004) found that depressive symptoms were independently associated with increased mortality in patients with congestive heart failure.

In essence, the neglect of PFAMC can have a cascading effect on a patient's health, accentuating physical symptoms, reducing treatment adherence, and severely limiting quality of life. This underscores the importance of early identification and integrated care approaches for individuals presenting with PFAMC.

Summary

Psychological Factors Affecting Other Medical Conditions (PFAMC) encompasses a complex interaction between psychological and medical issues, wherein mental or behavioral factors adversely impact a medical condition. This disorder is significant, not merely because of the coexistence of a psychological factor and a medical condition, but because the former plays a role in the onset, exacerbation, or hindered treatment of the latter. The diagnostic criteria necessitate a clear link between the psychological factor and the medical outcome, be it an increase in symptom severity, delayed recovery, or interference with treatment (American Psychiatric Association [APA], 2023).

The research shows that PFAMC can have broad implications if left untreated, such as worsening of medical symptoms, decreased adherence to treatment, reduced quality of life, and even an elevated risk of mortality. The origins and causes involve biological, psychological, and social contributors, further highlighting the importance of a comprehensive understanding and approach to treatment. Current interventions range from psychological therapies like Cognitive Behavioral Therapy to medical interventions and patient education. An integrated, multidisciplinary approach is often advocated to ensure optimal outcomes for individuals presenting with PFAMC (Fava et al., 2017).

PFAMC underscores the interplay between the mind and body, and addressing this disorder's psychological and medical components is essential for improving patient outcomes and overall well-being.

References

Anda, R. F., Felitti, V. J., Bremner, J. D., Walker, J. D., Whitfield, C., Perry, B. D., ... & Giles, W. H. (2006). The enduring effects of abuse and related adverse experiences in childhood. European Archives of Psychiatry and Clinical Neuroscience, 256(3), 174-186.

Asmundson, G. J., & Taylor, S. (1996). Role of anxiety sensitivity in pain-related fear and avoidance. Journal of Behavioral Medicine, 19(6), 577-586.

Bair, M. J., Robinson, R. L., Katon, W., & Kroenke, K. (2003). Depression and pain comorbidity: A literature review. Archives of Internal Medicine, 163(20), 2433-2445.

Barth, J., Schumacher, M., & Herrmann-Lingen, C. (2004). Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosomatic Medicine, 66(6), 802-813.

Carney, R. M., Freedland, K. E., & Miller, G. E. (2002). Depression as a risk factor for cardiac mortality and morbidity: A review of potential mechanisms. Journal of Psychosomatic Research, 53(4), 897-902.

Cohen, S., Janicki-Deverts, D., & Miller, G. E. (2007). Psychological stress and disease. JAMA, 298(14), 1685-1687.

Cohen, S., Janicki-Deverts, D., & Turner, R. B. (2019). Psychological stress and susceptibility to upper respiratory infections. American Journal of Respiratory and Critical Care Medicine, 196(8), 968-973.

Dickens, C., McGowan, L., Clark-Carter, D., & Creed, F. (2002). Depression in rheumatoid arthritis: a systematic review of the literature with meta-analysis. Psychosomatic Medicine, 64(1), 52-60.

DiMatteo, M. R., Lepper, H. S., & Croghan, T. W. (2000). Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence. Archives of Internal Medicine, 160(14), 2101-2107.

Dimsdale, J. E. (2008). Psychological stress and cardiovascular disease. Journal of the American College of Cardiology, 51(13), 1237-1246.

Dimsdale, J. E., Sharma, N., & Sharpe, M. (2011). Physical symptoms, somatization, and associated distress. The Psychiatric Clinics of North America, 34(2), 272-284.

Drossman, D. A., Camilleri, M., Mayer, E. A., & Whitehead, W. E. (1999). AGA technical review on irritable bowel syndrome. Gastroenterology, 117(6), 1238-1254.

Evans, D. L., Charney, D. S., Lewis, L., Golden, R. N., Gorman, J. M., Krishnan, K. R., ... & Valvo, W. J. (2005). Mood disorders in the medically ill: scientific review and recommendations. Biological Psychiatry, 58(3), 175-189.

Evans, D. L., Charney, D. S., Lewis, L., Golden, R. N., Gorman, J. M., Krishnan, K. R., ... & Valvo, W. J. (2005). Mood disorders in the medically ill: scientific review and recommendations. Biological Psychiatry, 58(3), 175-189.

Fava, G. A., Cosci, F., Sonino, N., & Wise, T. N. (2017). The Psychosomatic Assessment: Strategies to Improve Clinical Practice. Advances in Psychosomatic Medicine, 37, 1-18.

Fergus, T. A., & Spada, M. M. (2020). Health anxiety and medical utilization: The moderating effect of age among patients in primary care. Journal of Anxiety Disorders, 72, 102211.

Frank, D. L., Khorshid, L., Kiffer, J. F., Moravec, C. S., & McKee, M. G. (2010). Biofeedback in medicine: who, when, why and how? Mental Health in Family Medicine, 7(2), 85.

Frankenburg, F. R., & Zanarini, M. C. (2006). The association between borderline personality disorder and chronic medical illnesses, poor health-related lifestyle choices, and costly forms of health care utilization. Journal of Clinical Psychiatry, 67(12), 1916-1922.

Goyal, M., Singh, S., Sibinga, E. M., Gould, N. F., Rowland-Seymour, A., Sharma, R., ... & Ranasinghe, P. D. (2014). Meditation programs for psychological stress and well-being: a systematic review and meta-analysis. JAMA Internal Medicine, 174(3), 357-368.

Henningsen, P., Zimmermann, T., & Sattel, H. (2003). Medically unexplained physical symptoms, anxiety, and depression: a meta-analytic review. Psychosomatic Medicine, 65(4), 528-533.

Hofmann, S. G., Asnaani, A., Vonk, I. J., Sawyer, A. T., & Fang, A. (2012). The efficacy of cognitive behavioral therapy: A review of meta-analyses. Cognitive Therapy and Research, 36(5), 427-440.

Jackson, J. R., Eaton, W. W., Cascella, N. G., Fasano, A., & Kelly, D. L. (2020). Neurologic and psychiatric manifestations of celiac disease and gluten sensitivity. Psychiatric Quarterly, 91(1), 141-152.

Katon, W., Lin, E., & Kroenke, K. (2003). The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. General Hospital Psychiatry, 25(2), 89-95.

Katon, W., Russo, J., Lin, E. H., Heckbert, S. R., Karter, A. J., Williams, L. H., ... & Von Korff, M. (2003). Diabetes and poor disease control: Is comorbid depression associated with poor medication adherence or lack of treatment intensification? Psychosomatic Medicine, 65(6), 965-972.

Kendler, K. S., Gardner, C. O., & Prescott, C. A. (2002). Toward a comprehensive developmental model for major depression in women. American Journal of Psychiatry, 159(7), 1133-1145.

Kroenke, C. H., Michael, Y. L., Poole, E. M., Kwan, M. L., Nechuta, S., Leas, E., ... & Pierce, J. P. (2021). Postdiagnosis social networks and breast cancer mortality in the After Breast Cancer Pooling Project. Cancer, 127(7), 1228-1237.

Lehrer, P. M., & Gevirtz, R. (2014). Heart rate variability biofeedback: how and why does it work? Frontiers in Psychology, 5, 756.

Lorig, K. R., & Holman, H. R. (2003). Self-management education: history, definition, outcomes, and mechanisms. Annals of Behavioral Medicine, 26(1), 1-7.

Miller, A. H., Maletic, V., & Raison, C. L. (2009). Inflammation and its discontents: The role of cytokines in the pathophysiology of major depression. Biological Psychiatry, 65(9), 732-741.

Raison, C. L., & Miller, A. H. (2003). When not enough is too much: The role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. American Journal of Psychiatry, 160(9), 1554-1565.

Rief, W., & Broadbent, E. (2007). Explaining medically unexplained symptoms-models and mechanisms. Clinical Psychology Review, 27(7), 821-841.

Rief, W., Nestoriuc, Y., & Von Lilienfeld-Toal, A. (2008). Differences in adverse effect reporting in placebo groups in SSRI and tricyclic antidepressant trials: a systematic review and meta-analysis. Drug Safety, 31(10), 891-900.

Rozanski, A., Blumenthal, J. A., & Kaplan, J. (1999). Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation, 99(16), 2192-2217.

Simon, G. E., Von Korff, M., Saunders, K., Miglioretti, D. L., Crane, P. K., van Belle, G., & Kessler, R. C. (2009). Association between obesity and psychiatric disorders in the US adult population. Archives of General Psychiatry, 66(7), 791-800.

Sirri, L., & Fava, G. A. (2013). Diagnostic criteria for psychosomatic research and somatic symptom disorders. International Review of Psychiatry, 25(1), 19-30.

Smith, B. W., & Zautra, A. J. (2008). Vulnerability and resilience in women with arthritis: Test of a two-factor model. Journal of Consulting and Clinical Psychology, 76(5), 799-810.

Sullivan, L. E., Fiellin, D. A., & O’Connor, P. G. (2005). The prevalence and impact of alcohol problems in major depression: a systematic review. American Journal of Medicine, 118(4), 330-341.

Surwit, R. S., Schneider, M. S., & Feinglos, M. N. (1992). Stress and diabetes mellitus. Diabetes Care, 15(10), 1413-1422.

Zeidan, F., & Vago, D. R. (2019). Mindfulness meditation-based pain relief: a mechanistic account. Annals of the New York Academy of Sciences, 1373(1), 114-127.